Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in coronary stent technology.

Elliot J Smith1, Ajay K Jain, Martin T Rothman

  • 1Specialist Registrar in Cardiology, London Chest Hospital, London, United Kingdom.

Journal of Interventional Cardiology
|November 17, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A nationwide multi-centre survey of 12,500 cases of upper gastrointestinal bleeding: A report of Indian Society of Gastroenterology Task Force on acute upper gastrointestinal bleed.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

Clinically distinct metabotypes of pediatric MASLD identified through unsupervised clustering of NASH CRN data.

Nature communications·2026
Same author

Proteomic and Lipidomic Atlas of Gut-Associated Lymph and Venous Depots in Female Piglets.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Reclassifying pediatric NAFLD using the steatotic liver disease framework: A multicenter retrospective study from the NASH CRN.

Hepatology (Baltimore, Md.)·2025
Same author

Advancing the Diagnosis and Management of Genetic Cholestatic Liver Disease in Adults.

Digestive diseases and sciences·2025
Same author

Correction: ADAPT-3D:accelerated deep adaptable processing of tissue for 3-dimensional fluorescence tissue imaging for research and clinical settings.

Scientific reports·2025
Same journal

Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular Disease.

Journal of interventional cardiology·2024
Same journal

Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension.

Journal of interventional cardiology·2024
Same journal

Examining the Outcomes of Hybrid Coronary Revascularization in Acute STEMI Patients from 2015 to 2022.

Journal of interventional cardiology·2024
Same journal

Clinical and Laboratory Predictors of Long-Term Outcomes after Catheter Ablation for a Ventricular Electrical Storm.

Journal of interventional cardiology·2024
Same journal

Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial.

Journal of interventional cardiology·2024
Same journal

Mitral Valve Transcatheter Edge-to-Edge Repair Volumes and Trends.

Journal of interventional cardiology·2023
See all related articles

Drug-eluting stents (DES) reduce restenosis but raise concerns about late stent thrombosis. This review examines current DES limitations and future technological advancements in coronary interventions.

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering
  • Pharmacology

Background:

  • Coronary stents evolved from mechanical devices to drug delivery platforms.
  • Drug-eluting stents (DES) significantly reduced restenosis rates after angioplasty.

Purpose of the Study:

  • To review limitations of current drug-eluting stents.
  • To explore recent advances in stent technology for future clinical practice.

Main Methods:

  • Literature review of coronary stent technology.
  • Analysis of platform, carrier, and pharmacological advancements.
  • Discussion of clinical implications and future directions.

Main Results:

  • DES have decreased restenosis but introduced risks of late stent thrombosis.

Related Experiment Videos

  • Concerns exist regarding antiplatelet therapy cessation after DES implantation.
  • Emerging technologies aim to address current DES limitations.

    • Conclusions:

    • Future coronary stent technology will likely involve improved platforms, drug carriers, and novel pharmacological approaches.
    • Addressing late stent thrombosis remains a critical challenge in DES development.
    • Technological innovation is key to optimizing outcomes in coronary artery disease treatment.